Skip to content

Clinical trials

Completed Retinitis Pigmentosa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Status: Completed Country / region: United States Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20033
20041
20052
20062
20074
20081
20091
20101
20124
20131
20142
20154
20176
20183
20194
20202
20214
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)10
Johns Hopkins University5
Neurotech Pharmaceuticals3
QLT Inc.3
jCyte, Inc3
Nanoscope Therapeutics Inc.2
Retina Foundation of the Southwest2
Second Sight Medical Products2
AbbVie1
Aldeyra Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa55
Eye Diseases6
Usher Syndromes6
Macular Degeneration5
Retinal Diseases5
Leber Congenital Amaurosis4
Retinal Degeneration4
Glaucoma3
Vision Disorders3
Eye Diseases, Hereditary2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.